Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christine Fagnoni-Legat"'
Autor:
Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, Dimitri Pureur, François Ghiringhelli, Eric Assenat, Pascal Hammel, Olivier Rosmorduc, Morgane Stouvenot, Manon Allaire, Mohamed Bouattour, Hélène Regnault, Serge Fratte, Eric Raymond, Emilie Soularue, Stéphanie Husson-Wetzel, Vincent Di Martino, Allison Muller, Anne-Laure Clairet, Christine Fagnoni-Legat, Olivier Adotevi, Aurélia Meurisse, Dewi Vernerey, Christophe Borg
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Several cancer immunotherapies that target the PD-L1/PD-1 pathway show promising clinical activity in patients with hepatocellular carcinoma (HCC). However, the standard of care in first-line treatment with atezolizumab (anti-PD-L
Externí odkaz:
https://doaj.org/article/39a0fdecdfae4b14bb524649b02db940
Autor:
Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, Marion Jacquin, Francois Ghiringhelli, Christelle de la Fouchardière, Benoit You, Tristan Maurina, Elsa Kalbacher, Fernando Bazan, Guillaume Meynard, Anne-Laure Clairet, Christine Fagnoni-Legat, Laurie Spehner, Adeline Bouard, Dewi Vernerey, Aurélia Meurisse, Stefano Kim, Christophe Borg, Laura Mansi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThere is a strong rational of using anti–programmed cell death protein-1 and its ligand (anti–PD-1/L1) antibodies in human papillomavirus (HPV)–induced cancers. However, anti–PD-1/L1 as monotherapy induces a limited number of object
Externí odkaz:
https://doaj.org/article/90ac113021e14bb9a976565c61b79c86
Autor:
Margaux Damerval, Christine Fagnoni-Legat, Aurélien Louvrier, Sarah Fischer, Samuel Limat, Anne-Laure Clairet, Virginie Nerich, Isabelle Madelaine, Marie Kroemer
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Since 2007, a new class of biologic products for human use called “advanced therapy medicinal products (ATMP)” have been legally integrated in the European Medical Agency. They consist of recombinant nucleic acid, engineered cells, cells, or tiss
Externí odkaz:
https://doaj.org/article/18cd314a34e54014821d82dea62b4681
Autor:
Xavier Pivot, Laura Mansi, Stephanie Servagi-Vernat, Delphine Delroeux, Julien Pauchot, Lionel Aherfi, Nicolas Isambert, Christine Fagnoni-Legat, Elsa Kalbacher, Antoine Thiery-Vuillemin, Loic Chaigneau
Publikováno v:
Rare Tumors, Vol 3, Iss 3, Pp e29-e29 (2011)
Solitary fibrous tumor is a rare tumor type and has an unpredictable course. Local recurrence rate varies between 9 and 19 %, and rate of metastatic involvement between 0 and 36 %. It is characterized by a typical architecture and immuno-histochemist
Externí odkaz:
https://doaj.org/article/16f839d13af14e579af2fd985a946f18
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet, Aurélia Meurisse, Caroline Laheurte, Hamadi Almotlak, Marion Jacquin, Vincent Kaulek, Laura Boullerot, Marine Malfroy, Emeline Orillard, Guillaume Eberst, Aurélie Lagrange, Laure Favier, Marie Gainet-Brun, Ludovic Doucet, Luis Teixeira, Zineb Ghrieb, Anne-Laure Clairet, Yves Guillaume, Marie Kroemer, Didier Hocquet, Mélanie Moltenis, Samuel Limat, Elisabeth Quoix, Céline Mascaux, Didier Debieuvre, Christine Fagnoni-Legat, Christophe Borg, Virginie Westeel
Publikováno v:
Journal of Clinical Oncology. 41:373-384
PURPOSE Universal cancer peptide–based vaccine (UCPVax) is a therapeutic vaccine composed of two highly selected helper peptides to induce CD4+ T helper-1 response directed against telomerase. This phase Ib/IIa trial was designed to test the safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89a35baf49f743bcea131115f667da9
https://doi.org/10.1200/jco.22.00096
https://doi.org/10.1200/jco.22.00096
Autor:
Marion Richard, Didier Hocquet, Didier Mazel, Christine Fagnoni-Legat, Virginie Nerich, Alexandre Meunier, Xavier Bertrand, Olivier Adotevi
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 2019, 74 (6), pp.1572-1577. ⟨10.1093/jac/dkz070⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 74 (6), pp.1572-1577. ⟨10.1093/jac/dkz070⟩
Journal of Antimicrobial Chemotherapy, 2019, 74 (6), pp.1572-1577. ⟨10.1093/jac/dkz070⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 74 (6), pp.1572-1577. ⟨10.1093/jac/dkz070⟩
International audience; BACKGROUND:Infections with antibiotic-resistant pathogens in cancer patients are a leading cause of mortality. Cancer patients are treated with compounds that can damage bacterial DNA, potentially triggering the SOS response,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba8fdee4c603dee85365989bf981a236
https://pubmed.ncbi.nlm.nih.gov/30789224
https://pubmed.ncbi.nlm.nih.gov/30789224
Autor:
Antoine Thiery-Vuillemin, Nicolas Isambert, Xavier Pivot, Christine Fagnoni-Legat, Laura Mansi, Delphine Delroeux, Stephanie Servagi-Vernat, Lionel Aherfi, Elsa Kalbacher, Julien Pauchot, Loic Chaigneau
Publikováno v:
Rare Tumors, Vol 3, Iss 3, Pp e29-e29 (2011)
Rare Tumors
Rare Tumors
Solitary fibrous tumor is a rare tumor type and has an unpredictable course. Local recurrence rate varies between 9 and 19%, and rate of metastatic involvement between 0 and 36 %. It is characterized by a typical architecture and immuno-histochemistr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::806089ef0c9a7120bd4d0f88fcf30557
http://www.pagepress.org/journals/index.php/rt/article/view/2754
http://www.pagepress.org/journals/index.php/rt/article/view/2754